Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
953.97
886.47
853.39
648.28
503.26
558.72
534.96
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
953.97
886.47
853.39
648.28
503.26
558.72
534.96
Raw Material Cost
112.18
99.07
99.26
81.00
67.23
67.98
68.59
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
251.20
225.01
238.29
147.92
133.68
123.87
117.28
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.38
0.24
0.24
0.38
0.00
0.00
0.00
Selling and Distribution Expenses
552.30
457.79
463.89
358.39
298.60
326.57
307.06
Other Expenses
-21.31
-18.74
-18.37
-9.41
-10.52
-9.10
-8.66
Total Expenditure (Excl Depreciation)
702.97
594.71
617.99
493.64
394.28
427.45
406.37
Operating Profit (PBDIT) excl Other Income
251
291.8
235.39999999999998
154.60000000000002
109
131.3
128.6
Other Income
58.32
-31.10
22.83
25.11
30.29
20.65
4.07
Operating Profit (PBDIT)
323.82
269.25
265.55
194.84
150.00
162.65
143.00
Interest
0.38
0.24
0.24
0.38
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
841.79
787.40
754.13
567.28
436.03
490.74
466.37
Depreciation
18.46
11.50
12.28
13.84
14.07
14.12
13.22
Profit Before Tax
304.99
257.51
253.03
180.62
135.94
148.53
129.78
Tax
40.14
34.39
28.71
20.27
18.22
18.67
17.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
261.61
219.33
219.09
154.67
114.90
129.72
112.91
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
261.61
219.33
219.09
154.67
114.90
129.72
112.91
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.61
-0.35
-0.32
-0.40
-0.55
0.14
-0.13
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
261.00
218.98
218.77
154.26
114.35
129.86
112.78
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,430.06
2,248.64
1,904.84
1,688.43
1,601.99
1,569.48
463.74
Earnings per share (EPS)
1.31
1.13
1.17
0.83
0.61
0.69
0.6
Diluted Earnings per share
1.31
1.13
1.17
0.83
0.61
0.69
0.6
Operating Profit Margin (Excl OI)
25.9%
32.58%
27.0%
24.05%
20.99%
22.89%
23.5%
Gross Profit Margin
33.91%
30.35%
31.09%
30.0%
29.81%
29.11%
26.73%
PAT Margin
27.42%
24.74%
25.67%
23.86%
22.83%
23.22%
21.11%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 7.61% vs 3.88% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 19.18% vs 0.09% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -11.59% vs 23.73% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 100.00% vs 0.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Jiangsu Jibeier Pharmaceutical Co. Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
953.97
0
953.97
Other Operating Income
0.00
0.00
0.00
Total Operating income
953.97
0
953.97
Raw Material Cost
112.18
0
112.18
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
251.20
0
251.20
Power Cost
0
0
0.00
Manufacturing Expenses
0.38
0
0.38
Selling and Distribution Expenses
552.30
0
552.30
Other Expenses
-21.31
0.00
-21.31
Total Expenditure (Excl Depreciation)
702.97
0
702.97
Operating Profit (PBDIT) excl Other Income
251.00
0.00
251.00
Other Income
58.32
0
58.32
Operating Profit (PBDIT)
323.82
0
323.82
Interest
0.38
0
0.38
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
841.79
0
841.79
Depreciation
18.46
0
18.46
Profit Before Tax
304.99
0
304.99
Tax
40.14
0
40.14
Provisions and contingencies
0
0
0.00
Profit After Tax
261.61
0
261.61
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
261.61
0
261.61
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.61
0
-0.61
Other related items
0.00
0.00
0.00
Consolidated Net Profit
261.00
0
261.00
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,430.06
0
2,430.06
Earnings per share (EPS)
1.31
0
1.31
Diluted Earnings per share
1.31
0
1.31
Operating Profit Margin (Excl OI)
25.90%
0%
0.00
25.90%
Gross Profit Margin
33.91%
0%
0.00
33.91%
PAT Margin
27.42%
0%
0.00
27.42%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 95.40 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 7.61% vs 3.88% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 26.10 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 19.18% vs 0.09% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.55 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -11.59% vs 23.73% in Dec 2024
Annual - Interest
Interest 0.04 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 100.00% vs 0.00% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.90%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






